Richard T. LeBuhn
CIK 1428664 · last filed 2026-06-22
Richard T. LeBuhn is a corporate insider who has filed 20 SEC Form 4 insider transactions across 5 companies since 2008. The most recent filing, for STAA, was dated Jun 22, 2026. Across all open-market trades the lifetime net is +$94.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $781 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$781
5
20
$94.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| STAA | Director | — | $24.64 | — | $0 | 2 | 2026-06-22 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | Director | 25,000 | — | — | $22.1K | 4 | 2018-06-25 |
| Asterias Biotherapeutics, Inc. (AST.WS) Delisted | Director | 25,000 | — | — | $62.8K | 3 | 2017-04-03 |
| BTX | Director | 87 | $8.98 | $781 | $10.0K | 6 | 2016-10-31 |
| COMARCO INC (CMRO) Delisted | Director | 37,301 | — | — | $0 | 5 | 2010-07-07 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-22 | STAA | Grant (A) | — | $0 | EDGAR |
| 2026-03-10 | STAA | Grant (A) | — | $0 | EDGAR |
| 2018-06-25 | Asterias Biotherapeutics, Inc. (AST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-04-03 | Asterias Biotherapeutics, Inc. (AST.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-10-31 | BTX | Grant (A) | — | $0 | EDGAR |
| 2016-07-01 | Asterias Biotherapeutics, Inc. (AST.WS) Delisted | Buy (P) | +5,000 | $11.9K | EDGAR |
| 2016-05-17 | Asterias Biotherapeutics, Inc. (AST.WS) Delisted | Buy (P) | +15,000 | $50.9K | EDGAR |
| 2016-03-01 | Asterias Biotherapeutics, Inc. (AST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-07-13 | Asterias Biotherapeutics, Inc. (AST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-06-26 | Asterias Biotherapeutics, Inc. (AST) Delisted | Buy (P) | +5,000 | $22.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.